Hypera SA (HYPMY)
5.85
+0.06
(+1.04%)
USD |
OTCM |
May 17, 16:00
Hypera Debt to Equity Ratio: 0.906 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.906 |
December 31, 2023 | 0.8659 |
September 30, 2023 | 0.8666 |
June 30, 2023 | 0.8921 |
March 31, 2023 | 0.815 |
December 31, 2022 | 0.9094 |
September 30, 2022 | 0.8469 |
June 30, 2022 | 0.7909 |
March 31, 2022 | 0.8325 |
December 31, 2021 | 0.7537 |
September 30, 2021 | 0.7695 |
June 30, 2021 | 0.6905 |
March 31, 2021 | 0.715 |
December 31, 2020 | 0.5992 |
September 30, 2020 | 0.6027 |
June 30, 2020 | 0.5345 |
March 31, 2020 | 0.2325 |
December 31, 2019 | 0.1619 |
September 30, 2019 | 0.0627 |
June 30, 2019 | 0.0651 |
March 31, 2019 | 0.0676 |
December 31, 2018 | 0.0704 |
September 30, 2018 | 0.0633 |
June 30, 2018 | 0.0531 |
March 31, 2018 | 0.0644 |
Date | Value |
---|---|
December 31, 2017 | 0.0874 |
September 30, 2017 | 0.0819 |
June 30, 2017 | 0.0846 |
March 31, 2017 | 0.1044 |
December 31, 2016 | 0.1042 |
September 30, 2016 | 0.1497 |
June 30, 2016 | 0.2115 |
March 31, 2016 | 0.2423 |
December 31, 2015 | 0.6256 |
September 30, 2015 | 0.7068 |
June 30, 2015 | 0.6544 |
March 31, 2015 | 0.6755 |
December 31, 2014 | 0.6506 |
September 30, 2014 | 0.6355 |
June 30, 2014 | 0.6119 |
March 31, 2014 | 0.6012 |
December 31, 2013 | 0.5759 |
September 30, 2013 | 0.7075 |
June 30, 2013 | 0.6567 |
March 31, 2013 | 0.6347 |
December 31, 2012 | 0.6461 |
September 30, 2012 | 0.6972 |
June 30, 2012 | 0.6636 |
March 31, 2012 | 0.6371 |
December 31, 2011 | 0.8037 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0627
Minimum
Sep 2019
0.9094
Maximum
Dec 2022
0.6456
Average
0.7616
Median
Debt to Equity Ratio Benchmarks
Raia Drogasil SA | 0.4677 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 5.037B |
Total Liabilities (Quarterly) | 2.701B |
Shareholders Equity (Quarterly) | 2.334B |
Current Ratio | 1.807 |
Net Debt Paydown Yield | -1.34% |